- Trials with a EudraCT protocol (119)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
119 result(s) found for: CPR.
Displaying page 1 of 6.
EudraCT Number: 2004-001827-39 | Sponsor Protocol Number: SIFIM | Start Date*: 2004-09-15 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: NATIONAL, MULTICENTER, RANDOMISED, OPEN STUDY TO VALUATE THE EFFICACY OF DIFFERENT THERAPEUTIC STRATEGIES TO AVOID THE IMMUNOLOGIC FAILURE IN MULTIRESISTENT HIV-1 INFECTED PATIENTS. | |||||||||||||
Medical condition: HIV TREATMENT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-000603-18 | Sponsor Protocol Number: Q10DOWN | Start Date*: 2004-06-11 |
Sponsor Name:AZIENDA OSPEDALIERA UMBERTO I | ||
Full Title: ubiquinone in Down syndrome | ||
Medical condition: Down syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003293-25 | Sponsor Protocol Number: MM2005 | Start Date*: 2005-10-05 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: A PHASE II, MULTI-CENTER, OPEN LABEL STUDY OF MELPHALAN, PREDNISONE, THALIDOMIDE AND DEFIBROTIDE IN ADVANCED AND REFRACTORY MULTIPLE MYELOMA PATIENTS | |||||||||||||
Medical condition: MULTIPLE MYELOMA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001457-16 | Sponsor Protocol Number: RINKAST | Start Date*: 2005-09-06 | |||||||||||
Sponsor Name:UNIVERSITA' DEGLI STUDI DI UDINE | |||||||||||||
Full Title: RANDOMIZED, DOUBLE BLIND TRIAL MONTELUKAST VERSUS LEVOCETIRIZINE IN THE TREATMENT OF SEASONAL RHINITIS AND CONJUNCTIVITIS IN CHILDREN 6-14 YEARS OLD | |||||||||||||
Medical condition: TREATMENT OF ALLERGIC SEASONAL RHINITIS AND ALLERGIC SEASONAL CONJUCTIVITIS | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001723-13 | Sponsor Protocol Number: 405 | Start Date*: 2020-04-17 |
Sponsor Name:GROUPE HOSPITALIER PARIS SAINT-JOSEPH | ||
Full Title: A randomized trial of efficacy and safety of an early OUTpatient treatment of COVID-19 in patients with risk factor for poor outcome : a strategy to prevent hospitalization : OUTCOV Study | ||
Medical condition: COVID-19 patients with risk factor for poor outcome | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-000855-14 | Sponsor Protocol Number: 01-865-2005 | Start Date*: 2005-07-18 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | |||||||||||||
Full Title: Multicenter, not controlled, prospectic clinical phase IV study: safety and efficacy of an immunosuppressive regimen with Thymoglobuline and Rapamune in patients receiving a renal transplantation f... | |||||||||||||
Medical condition: Acute rejection prophylaxis after single-double kidney transplantation from marginal donors making use of a not nephrotoxic immunosuppressive regimen. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004525-99 | Sponsor Protocol Number: ESD | Start Date*: 2004-11-09 | |||||||||||
Sponsor Name:IST. DI RICERCHE FARMACOLOG. M. NEGRI | |||||||||||||
Full Title: A randomized, prospective, double-blind study to evaluate the effects on lipid profile of combined Ezetimibe and Simvastatin therapy as compared to Simvastatin alone in people with type 2 diabetes | |||||||||||||
Medical condition: Effects of Ezetimibe-simvastatin combined therapy in ameliorating the lipid profile and the overall cardiovascular and renal risk profile of patients with type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002310-39 | Sponsor Protocol Number: Vasta2019 | Start Date*: 2019-09-23 |
Sponsor Name:Norrtälje Sjukhus, Tiohundra AB | ||
Full Title: VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial | ||
Medical condition: In hospital cardiac arrest | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004763-31 | Sponsor Protocol Number: CRO.CO.DEX | Start Date*: Information not available in EudraCT |
Sponsor Name:EryDel S.p.A. | ||
Full Title: Therapy with dexamethasone intra-erythrocytes in patients with Crohn disease and ulcerative colitis | ||
Medical condition: patients with Crohn’s Disease and Ulcerative Colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002966-12 | Sponsor Protocol Number: MD-04-01 | Start Date*: 2005-03-23 | |||||||||||
Sponsor Name:TRASTEC | |||||||||||||
Full Title: PHYSIOPATHOLOGY OF NONALCOHOLIC HEPATIC STEATOSIS AND EFFICACY OF SILYMARIN IN THE THERAPY OF NONALCOHOLIC HEPATIC STEATOSIS | |||||||||||||
Medical condition: Nonalcoholic hepatic steatosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000996-16 | Sponsor Protocol Number: 694/30.06.04 | Start Date*: 2004-06-30 | |||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I | |||||||||||||
Full Title: Silence Study - Longitudinal study on the use of aspirin versus placebo in patients with silent cerebral infarcts | |||||||||||||
Medical condition: prevention of occlusive ischemic events in patient with transient ischemic attacs or after brain infarct, | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003858-26 | Sponsor Protocol Number: A00392 | Start Date*: 2005-03-02 |
Sponsor Name:UCB PHARMA | ||
Full Title: A pilot, open, monocenter, randomized two parallel groups, clinical efficacy trial: Comparison continuous versus on demand regimen of treatment with Levocetirizine 5 mg oral tablets, once a day, in... | ||
Medical condition: Respiratory Allergy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-002376-42 | Sponsor Protocol Number: ASL603LIOM02 | Start Date*: 2005-01-12 | |||||||||||
Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO NORD OVEST | |||||||||||||
Full Title: PHASE II TRIAL OF SEQUENTIAL CHEMO-IMMUNOTHERAPY WITH CAPECITABINE PLUS INTERFERON ALPHA2a FOLLOWED BY IL-2 IN PATIENTS WITH METASTATIC KIDNEY CANCER | |||||||||||||
Medical condition: TREATMENT OF METASTATIC KIDNEY CANCER | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004498-31 | Sponsor Protocol Number: SC05-02 | Start Date*: 2005-10-05 | |||||||||||
Sponsor Name:FONDAZIONE SANTA LUCIA | |||||||||||||
Full Title: Behaviour and cognition in Alzheimer s disease patients treated with the NMDA receptor antagonist memantine collelation with the apoptotic mechanisms. | |||||||||||||
Medical condition: Treatment of patients with Alzheimer s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004796-40 | Sponsor Protocol Number: 2018_58 | Start Date*: 2020-06-11 |
Sponsor Name:CHU de Lille | ||
Full Title: Multicenter Phase II study with dose-light escalation, intraoperative glioblastoma photodynamic therapy | ||
Medical condition: Glioblastoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) BE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001606-66 | Sponsor Protocol Number: OLZvsLMT-DB | Start Date*: 2005-06-16 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | |||||||||||||
Full Title: OLANZAPINE VS LAMOTRIGINE ADD-ON TO LITHIUM:EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
Medical condition: EFFICACY ON ANXIETY SYMPTOMS IN REMITTING BIPOLAR PATIENTS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000267-29 | Sponsor Protocol Number: 0059718/05GENII6A | Start Date*: 2006-01-01 | |||||||||||
Sponsor Name:Centro sociale oncologico | |||||||||||||
Full Title: Adjuvant chemotherapy in stage III colon carcinoma in patients age or 70 years. Feasibility of CAPOX scheme oxaliplatin 70 mg/mq days 1-8 and capecitabine 1000 mg/mq X 2 die days 1-14 every 21 da... | |||||||||||||
Medical condition: Colon carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004337-33 | Sponsor Protocol Number: APAF/01 | Start Date*: 2004-11-12 | |||||||||||
Sponsor Name:OSPEDALE S. RAFFAELE | |||||||||||||
Full Title: RANDOMIZED COMPARISON OF CIRCUMFERENTIAL PULMONARY VEIN ABLATION VERSUS ANTIARRHYTHMIC THERAPY FOR CURING PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION. (APAF STUDY) | |||||||||||||
Medical condition: APPLICATION OF CIRCUMFERENTIAL PULMONARY VEIN ABLATION IN THE TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-004538-14 | Sponsor Protocol Number: TACTOR-2013 | Start Date*: 2014-07-30 |
Sponsor Name:Azienda Ospedaliera Universitaria Integrata Verona | ||
Full Title: Identification of a specific systemic transcriptome able to differentiate patients with renal transplantation in chronic treatment with tacrolimus from those with mTOR inhibitors. | ||
Medical condition: Renal Transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002504-39 | Sponsor Protocol Number: HERO-19 | Start Date*: 2020-11-10 | |||||||||||
Sponsor Name:University Medical Center Hamburg-Eppendorf | |||||||||||||
Full Title: Hamburg Edoxaban foR anticoagulation in COvid-19 study | |||||||||||||
Medical condition: COVID-19 [Coronavirus disease 2019] | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
